- Home
- NMT vs RENB Comparison
NMT vs RENB Comparison
Compare NMT & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMT
- RENB
- Stock Information
- Founded
- NMT 1993
- RENB 2011
- Country
- NMT United States
- RENB United States
- Employees
- NMT N/A
- RENB N/A
- Industry
- NMT Finance/Investors Services
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- NMT Finance
- RENB Health Care
- Exchange
- NMT Nasdaq
- RENB Nasdaq
- Market Cap
- NMT 107.6M
- RENB 57.7M
- IPO Year
- NMT N/A
- RENB N/A
- Fundamental
- Price
- NMT $11.62
- RENB $0.17
- Analyst Decision
- NMT
- RENB
- Analyst Count
- NMT 0
- RENB 0
- Target Price
- NMT N/A
- RENB N/A
- AVG Volume (30 Days)
- NMT 19.1K
- RENB 993.7K
- Earning Date
- NMT 01-01-0001
- RENB 11-13-2025
- Dividend Yield
- NMT 3.21%
- RENB N/A
- EPS Growth
- NMT N/A
- RENB N/A
- EPS
- NMT N/A
- RENB N/A
- Revenue
- NMT N/A
- RENB N/A
- Revenue This Year
- NMT N/A
- RENB N/A
- Revenue Next Year
- NMT N/A
- RENB N/A
- P/E Ratio
- NMT N/A
- RENB N/A
- Revenue Growth
- NMT N/A
- RENB N/A
- 52 Week Low
- NMT $9.05
- RENB $0.17
- 52 Week High
- NMT $10.93
- RENB $2.10
- Technical
- Relative Strength Index (RSI)
- NMT 63.22
- RENB 31.45
- Support Level
- NMT $11.53
- RENB $0.18
- Resistance Level
- NMT $11.58
- RENB $0.22
- Average True Range (ATR)
- NMT 0.11
- RENB 0.02
- MACD
- NMT 0.03
- RENB -0.00
- Stochastic Oscillator
- NMT 90.00
- RENB 0.53
About NMT Nuveen Massachusetts Quality Municipal Income Fund
Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes and to enhance portfolio value relative to the Massachusetts municipal bond market by investing in tax-exempt Massachusetts municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.